Topic
Failure to Warn
200 published works
TortsProf Blog
Lindenfeld on Clear Evidence
Eric Lindenfeld has posted to SSRN Clear Evidence Clarified. The abstract provides:In 2009, the Supreme Court in Wyeth v. Levine articulated a standard of federal preemption for failure-to-warn claims in…
Drug & Device Law
Another Gadolinium Win for Defendants
We’ve brought you some great news from the gadolinium contrast agent litigation last year and the hits just keeping on coming. This time out of federal court in Arizona. And…
Drug & Device Law
Wrong Court and Wrong-er Reasoning − Ignoring 75 Years of Controlling Precedent
By Bexis
The opinion, Schrecengost v. Coloplast Corp., 2019 WL 6465398 (W.D. Pa. Dec. 2, 2019), recently “predicted” that Pennsylvania would allow strict liability design and warning defect claims in cases involving…
Drug & Device Law
Not All California Trial Rulings Are Horrible
Sort of like hail in Alabama. It happens, but when it does it’s an event. Not like say picking a perfect NCAA March Madness bracket (1 in 2.4 trillion). Maybe…
Drug & Device Law
Tenth Circuit Finally Shuts the Door Completely on Cerveny
We’ve been posting about this case since 2016 when the district court first dismissed plaintiff’s failure to warn claim as preempted on the grounds that there was clear evidence the…
Drug & Device Law
Taxotere Court Excludes Expert Opinion on How the Medical Community Would Have Reacted to a Different Warning
We write today about a partial exclusion of a plaintiff expert in the upcoming Taxotere bellwether trial. We have blogged about other aspects of the Taxotere litigation previously. (Here and…
Constitutional Law Prof Blog
Court Clarifies Preemption Standard in Pharmaceutical Failure-to-Warn Cases
Steven D. Schwinn, John Marshall Law SchoolThe Supreme Court ruled on Monday that a drug manufacturer, in order to escape state-tort failure-to-warn liability, must show that "it fully informed the…
Drug & Device Law
Warning Causation Sinks Another Generic “Failure To Update” Claim
It’s Delaware week here at the DDL Blog. A couple of days ago we brought you a particularly clear-minded order rejecting innovator liability in the First State (so nicknamed because…
Drug & Device Law
A Generic Drug Failure to Warn Claim?
No. It can’t be. PLIVA, Inc. v. Mensing, 564 U.S. 604 (2011) took care of that. Just look at our generic preemption scorecard – the proof is there. The warnings…
Texas Personal Injury Law Blog
Uloric Lawsuits Allege Failure to Warn of Increases Risk of Death & Side-Effects
By Paul Cannon
Several Uloric lawsuits have been filed alleging that the maker, Takeda Pharmaceuticals, failed to warn consumers of know risks of serious deadly side-effects affecting the heart, kidneys, liver, bone marrow…